Amylyx Pharmaceuticals Inc (AMLX)

Aug 09, 2025

Amylyx Pharmaceuticals Advances ALS Treatment with AMX0114 Clinical Trial - MSN

Aug 09, 2025

Aug 09, 2025

Amylyx anticipates Avexitide Phase III data in H1 2026 while expanding rare disease pipeline - MSN

Aug 09, 2025

Aug 09, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025

Aug 08, 2025

Promising Market Potential and Financial Outlook for Amylyx Pharmaceuticals Inc. Driven by Avexitide’s Advancements - TipRanks

Aug 08, 2025

Aug 08, 2025

Amylyx Pharmaceuticals Q2 2025 Earnings Preview - MSN

Aug 08, 2025

Aug 08, 2025

Amylyx Pharmaceuticals: Progress in Trials and Financials - TipRanks

Aug 08, 2025

Aug 07, 2025

Amylyx Pharmaceuticals: Strategic Progress in Neurodegenerative Therapies and the Path to Long-Term Value - AInvest

Aug 07, 2025

Aug 07, 2025

Amylyx in 2026: A High-Risk, High-Reward Biotech Catalyst Play - AInvest

Aug 07, 2025

Aug 07, 2025

Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunotherapies | DelveInsight - Yahoo Finance

Aug 07, 2025

Aug 07, 2025

Amylyx Pharmaceuticals' Q2 2025: Key Contradictions in PBH Patient Estimates, Trial Analysis, and Market Opportunities - AInvest

Aug 07, 2025

Aug 07, 2025

Amylyx Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Amylyx Pharmaceuticals’ Phase 3 Study on Avexitide: A Potential Game-Changer for Post-Bariatric Hypoglycemia - TipRanks

Aug 07, 2025

Aug 07, 2025

Promising Future for Amylyx Pharmaceuticals: Buy Rating Backed by Avexitide’s Market Potential - TipRanks

Aug 07, 2025

Aug 07, 2025

Amylyx (AMLX) Q2 Net Loss Narrows 43% - Nasdaq

Aug 07, 2025

Aug 07, 2025

Transcript : Amylyx Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025

Aug 07, 2025

Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results - BioSpace

Aug 07, 2025

Aug 07, 2025

Amylyx Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

Aug 07, 2025

Aug 06, 2025

Amylyx Pharmaceuticals: A Biotech Undervalued by Momentum and Milestones - AInvest

Aug 06, 2025

Aug 05, 2025

Amylyx Pharmaceuticals Advances Avexitide Study for Post-Bariatric Hypoglycemia - TipRanks

Aug 05, 2025

Aug 05, 2025

Amylyx Pharmaceuticals’ ALS Study: A Potential Game-Changer for Investors - TipRanks

Aug 05, 2025

Aug 05, 2025

Amylyx Pharmaceuticals Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView

Aug 05, 2025

Aug 04, 2025

After strategic reset, Amylyx downsizes, moves Cambridge HQ - The Business Journals

Aug 04, 2025

Aug 03, 2025

How volatile is Amylyx Pharmaceuticals Inc. stock compared to the marketAchieve exceptional returns with expert guidance - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Amylyx Pharmaceuticals Inc. stockMaximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Amylyx Pharmaceuticals Inc. in the next 12 monthsSkyrocketing profit margins - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Amylyx Pharmaceuticals Inc.Build wealth with long-term growth strategies - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Amylyx Pharmaceuticals Inc. stockBuild a portfolio that delivers consistent profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Amylyx Pharmaceuticals Inc. stock in 2025Fastest return on investment - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Amylyx Pharmaceuticals Inc. stock price move sharplyBuild wealth faster with consistent investment plans - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Amylyx Pharmaceuticals Inc. company’s key revenue driversBreakthrough wealth creation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Amylyx Pharmaceuticals Inc. stock higher in 2025Discover high-impact stocks for growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Amylyx Pharmaceuticals Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Amylyx Pharmaceuticals Inc. stockMaximize your gains with expert trading tips - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Amylyx Pharmaceuticals Inc. stock expected to show significant growthUnlock exclusive stock market forecasts - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX): Is Breakeven Near? - 富途牛牛

Aug 02, 2025

Aug 02, 2025

How many analysts rate Amylyx Pharmaceuticals Inc. as a “Buy”Unlock expert insights for smarter investing - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Does Amylyx Pharmaceuticals Inc. stock perform well during market downturnsTransform your portfolio with high-yield stocks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is it the right time to buy Amylyx Pharmaceuticals Inc. stockTriple-digit return opportunities - Jammu Links News

Aug 02, 2025

Aug 02, 2025

In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review - Physician's Weekly

Aug 02, 2025

Aug 01, 2025

What is the risk reward ratio of investing in Amylyx Pharmaceuticals Inc. stockChart Pattern Updates For Fast Growth - Jammu Links News

Aug 01, 2025

Aug 01, 2025

Why Amylyx Pharmaceuticals Inc. stock attracts strong analyst attentionTrend Reversal Signal Prediction Plan - beatles.ru

Aug 01, 2025

Aug 01, 2025

Amylyx Pharmaceuticals Inc. Rebound Backed by Sentiment ShiftVerified Signal From Chart Patterns Detected - metal.it

Aug 01, 2025

Jul 31, 2025

Amylyx Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025 - BioSpace

Jul 31, 2025

Jul 31, 2025

Amylyx Pharmaceuticals Announces Q2 2025 Earnings Call: Here's How to Join the Discussion - Stock Titan

Jul 31, 2025